Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.
Apperloo EM, Gorriz JL, Soler MJ, Cigarrán Guldris S, Cruzado JM, Puchades MJ, López-Martínez M, Waanders F, Laverman GD, van der Aart-van der Beek A, Hoogenberg K, van Beek AP, Verhave J, Ahmed SB, Schmieder RE, Wanner C, Cherney DZI, Jongs N, Heerspink HJL. Apperloo EM, et al. Among authors: van der aart van der beek a. Nat Med. 2024 Oct 25. doi: 10.1038/s41591-024-03327-6. Online ahead of print. Nat Med. 2024. PMID: 39455729
Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study.
van der Aart-van der Beek AB, Apperloo E, Jongs N, Rouw DB, Sjöström CD, Friedli I, Johansson L, van Raalte DH, Hoogenberg K, Heerspink HJL. van der Aart-van der Beek AB, et al. Diabetes Obes Metab. 2023 Jun;25(6):1758-1768. doi: 10.1111/dom.15033. Epub 2023 Mar 13. Diabetes Obes Metab. 2023. PMID: 36843215 Clinical Trial.
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
van Ruiten CC, van der Aart-van der Beek AB, IJzerman RG, Nieuwdorp M, Hoogenberg K, van Raalte DH, Heerspink HJL. van Ruiten CC, et al. Among authors: van der aart van der beek ab. Diabetes Obes Metab. 2021 Aug;23(8):1851-1858. doi: 10.1111/dom.14410. Epub 2021 May 14. Diabetes Obes Metab. 2021. PMID: 33908691 Free PMC article. Clinical Trial.
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials.
van der Aart-van der Beek AB, Cherney D, Laverman GD, Stefansson B, van Raalte DH, Hoogenberg K, Reyner D, Li Q, Di Tanna GL, Greasley PJ, Heerspink HJL. van der Aart-van der Beek AB, et al. Diabetes Obes Metab. 2021 Aug;23(8):1961-1967. doi: 10.1111/dom.14411. Epub 2021 May 14. Diabetes Obes Metab. 2021. PMID: 33908683 Free PMC article.
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.
van der Aart-van der Beek AB, Koomen JV, Dekkers CCJ, Barbour SJ, Boulton DW, Gansevoort RT, Greasley PJ, Abdul Gafor AH, Laverman GD, Li Q, Lim SK, Stevens J, Vervloet MG, Singh S, Cattran DC, Reich HN, Cherney DZI, Heerspink HJL. van der Aart-van der Beek AB, et al. Clin Pharmacokinet. 2021 Apr;60(4):517-525. doi: 10.1007/s40262-020-00956-1. Epub 2021 Feb 15. Clin Pharmacokinet. 2021. PMID: 33587286 Free PMC article. Clinical Trial.
Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasma and urine.
van der Aart-van der Beek AB, Wessels AMA, Heerspink HJL, Touw DJ. van der Aart-van der Beek AB, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Sep 1;1152:122257. doi: 10.1016/j.jchromb.2020.122257. Epub 2020 Jun 26. J Chromatogr B Analyt Technol Biomed Life Sci. 2020. PMID: 32663790 Free article.
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.
van der Aart-van der Beek AB, van Raalte DH, Guja C, Hoogenberg K, Suchower LJ, Hardy E, Sjöström CD, Heerspink HJL. van der Aart-van der Beek AB, et al. Diabetes Obes Metab. 2020 Sep;22(9):1556-1566. doi: 10.1111/dom.14067. Epub 2020 May 29. Diabetes Obes Metab. 2020. PMID: 32329160 Free PMC article. Clinical Trial.